+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR Study

Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR Study

Israel Medical Association Journal 10(6): 410-412

Acute generalized exanthematous pustulosis is a rare pustular severe cutaneous adverse reaction characterized by a rapid clinical course and unique histological findings. It is usually attributed to drugs, although other factors have also been implicated. To analyze demographic, clinical and laboratory data of AGEP cases in Israel, based on the RegisCAR study, a multinational European study. Patients included in the present study were actively recruited by the Israeli RegiSCAR network, which comprised 10 dermatology departments and units. The cases were validated by a multinational expert committee of dermatologists based on a standardized scoring system. Overall, 11 potential cases of AGEP were collected in Israel: 9 (81.8%) definite and 2 (19.2%) possible. The adjusted annual incidence of AGEP in Israel was 0.35/million/year. The nine definite cases that entered the analyses showed a male/female ratio of 0.28 with an age range of 10-60 years. Most cases were reported during the summer months. The clinical course and laboratory findings in most of our patients were in accordance with previous reports. A drug etiology was suspected in the majority of cases and consisted of analgesics (66.7%), antibiotics (22.2%) and non-steroidal anti-inflammatory drugs (11.1%) as the main culprit drugs. Whereas the clinical and laboratory findings of AGEP in Israel corresponded to the reported features of AGEP in the literature, some unique findings were noted, namely, marked female predominance, seasonality and a profile of culprit drugs.

(PDF 0-2 workdays service: $29.90)

Accession: 055205290

Download citation: RISBibTeXText

PMID: 18669133

Related references

Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). British Journal of Dermatology 157(5): 989-996, 2007

Generalized Pustulosis Diagnosed as Acute Generalized Exanthematous Pustulosis: Tzanck Smear and Pathological Evaluation of the Pustule Roof Can Provide Evidence for Early Diagnosis. Annals of Dermatology 27(5): 616-617, 2015

Acute generalized exanthematous pustulosis. Study of 22 cases. La Tunisie Medicale 88(12): 910-915, 2011

Pustulosis acuta generalisata is a post-streptococcal disease and is distinct from acute generalized exanthematous pustulosis. British Journal of Dermatology 133(1): 135-139, 1995

Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption. Journal of the American Academy of Dermatology 74(2): E29-E31, 2016

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. British Journal of Dermatology 169(6): 1223-1232, 2014

The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases. British Journal of Dermatology 163(6): 1245-1252, 2011

Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis. Archives of Dermatological Research 306(10): 933-938, 2015

The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. Journal of Cutaneous Pathology 37(12): 1220-1229, 2011

Immunohistochemical Comparison of IL-36 and the IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis. Annals of Dermatology 28(4): 451-456, 2016

Acute Generalized Exanthematous Pustulosis Induced by Amoxicillin/Clavulanic Acid: Report of a Case Presenting With Generalized Lymphadenopathy. Journal of Cutaneous Medicine and Surgery 19(6): 592-594, 2015

Acute generalized exanthematous pustulosis. Current Opinion in Allergy and Clinical Immunology 9(4): 322-328, 2010

Acute generalized exanthematous pustulosis. Pediatrie 44(5): 387-389, 1989

Acute generalized exanthematous pustulosis. Seminars in Cutaneous Medicine & Surgery 15(4): 244-249, 1996